Cite
Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles
MLA
Elodie Macho Fernandez, et al. Activation of Invariant Natural Killer T Lymphocytes in Response to the α-Galactosylceramide Analogue KRN7000 Encapsulated in PLGA-Based Nanoparticles and Microparticles. Feb. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....108948231e85cdb78136864d5f5c59c5&authtype=sso&custid=ns315887.
APA
Elodie Macho Fernandez, Jiang Chang, Josette Fontaine, Fabien Rodriguez, Emilie Bialecki, Sylvie Fournel, Didier Betbeder, Christelle Faveeuw, E. Werkmeister, François Trottein, Vanessa Krieger, Benoît Frisch, Béatrice Heurtault, & Christophe Ehret. (2012). Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Chicago
Elodie Macho Fernandez, Jiang Chang, Josette Fontaine, Fabien Rodriguez, Emilie Bialecki, Sylvie Fournel, Didier Betbeder, et al. 2012. “Activation of Invariant Natural Killer T Lymphocytes in Response to the α-Galactosylceramide Analogue KRN7000 Encapsulated in PLGA-Based Nanoparticles and Microparticles,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....108948231e85cdb78136864d5f5c59c5&authtype=sso&custid=ns315887.